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Abstract
Background: Portal vein thrombosis (PVT) is a rare condition associated with serious morbidity and mortality. The
objective of this study was to determine the frequency, clinical presentations, and risk factors of PVT from the set
of data firstly collected among the Southeast Asian population.
Methods: A retrospective study was undertaken to identify patients diagnosed with thrombosis of the portal
system and other abdominal veins. The hospital medical records were retrieved based on the selected ICD-10
codes. Clinical presentations were collected and risk factors determined.
Results: From 2000-2009, 467 hospital charts with designated ICD-10 codes of I81, I82.2, I82.3, I82.8, I82.9, or K55.0
were identified. PVT (I81) was the most common thrombosis (194 cases, 41.54%). The majority of PVT patients were
males (65%), older than 40 years (75%), and presented with abdominal distension/ascites (69%), splenomegaly
(54.6%), and abdominal pain (50.5%). Overall, the predominant risk factor was hepatocellular carcinoma (HCC)
(52.5%), followed by liver cirrhosis without cancer (9.3%), abdominal infection/inflammation (9.3%),
cholangiocarcinoma (8.2%), and abdominal intervention (7.7%). In young patients, abdominal interventions
including umbilical catheterization (23.1%) and hepatectomy (7.7%) were the most frequent risks whereas in older
cases, primary hepatobiliary cancer and cirrhosis (78%) were the major risks. Liver metastases from other organs
were infrequently found. Chronic hepatitis B virus (HBV) infection was the main etiology associated with cirrhosis/
HCC leading to PVT in this cohort. A third of the older PVT patients (age >40) had HBV and very few carried
hepatitis C virus (HCV) whereas none of the young PVT patients (age <20) had HBV or HCV. A variety of abdominal
infections/inflammations were also found including liver abscess, splenic abscess, cholangitis, cholecystitis,
pancreatitis, omphalitis, and abdominal tuberculosis. Single cases of systemic lymphangiomatosis and Klippel-
Trénaunay vascular malformation syndrome were also identified. Other thrombophilic conditions such as
myeloproliferative neoplasms, paroxysmal nocturnal hemoglobinuria, protein S deficiency, and anti-phospholipid
syndrome were rarely encountered.
Conclusion: HBV is the major risk of PVT in the Southeast Asian population. Several risk factors identified in this
population have rarely been described and some are remarkably different from those reported in the West. Host
and environmental factors may play a causal role in the initiation and development of PVT in various ethnicities
and geographic locations.
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Portal vein thrombosis (PVT) is considered a rare clini-
cal and pathological entity [1,2]. Thrombus formation
usually begins in the portal vein and sometimes extends
to other branches of the portal system such as splenic
vein or mesenteric vein [1,3,4]. The involved blood ves-
sels can be partially or totally occluded resulting in
increased portal venous outflow resistance from narrow-
ing or obstructed blood vessel lumens [1,3,4]. As throm-
bosis usually occurs gradually giving time for the
development of cavernous transformation as a result of
periportal collateralization around the occluded portal
vein, most patients are asymptomatic and do not seek
medical attention [2-4]. However, obvious signs of portal
hypertension such as splenomegaly, ascites, and massive
hemorrhage from esophageal and gastric varices could
also be found [1-6]. In the acute setting of moderate to
severe thrombus occlusion, abdominal pain may be the
striking presentation [2-4,6,7].
The prevalence of PVT is not well-defined due to its
rarity and initial asymptomatic nature. Nevertheless,
transient occlusion of the portal system is increasingly
being recognized during the diagnostic course of various
acute and chronic abdominal problems such as appendi-
citis, cholecystitis, cholangitis, pancreatitis, and other
intra-abdominal infections by ultrasonography [6,7]. A
proportion of patients with portal hypertension were
also found coincidentally to have a thrombus in the por-
tal system [1-4,6,8]. In a study of 701 hospitalized
patients with cirrhosis who underwent routine ultra-
sound screening, PVT could be identified in 11% of the
cases [3]. The largest series was a retrospective review
of 23,796 autopsies which revealed the prevalence of
PVT of 1% [1].
Since PVT is an uncommon and under-recognized
disorder and its true prevalence is not presently estab-
lished, it was of much interest to conduct a study to
explore the frequency, clinical presentations, and risk
factors of PVT at one of the largest hospitals in South-
east Asia. During a 10-year period, we were able to
find 194 PVT cases and the majority of them pre-
sented with a classical sign of portal hypertension and
advanced symptoms. Interestingly, the identifiable risk
factors appeared to be mostly associated with hepatitis
B virus (HBV) infection which is prevalent in this
region. The fact that HBV-associated cirrhosis and
hepatocellular carcinoma (HCC) are the predominant
risks for PVT is strikingly different from the major
risk factors in the Western reports. Other diseases
that have rarely been described were also discovered
in this series including Klippel-Trénaunay syndrome
[9], systemic lymphangiomatosis [10], and abdominal
tuberculosis [6].
2. Methods
This study was a retrospective analysis undertaken at
Siriraj Hospital which is the largest hospital in Thailand
comprising of more than 2,500 inpatient beds and more
than 2 million outpatient visits a year. Patients diag-
nosed with thrombosis of the portal system and other
abdominal veins from January 2000 to December 2009
were identified through the hospital’sc o m p u t e r i z e d
medical records based upon the Tenth Revision of the
International Statistical Classification of Diseases and
Related Health Problems (ICD-10) coding system http://
www.who.int/classifications/icd/en/. The study was
approved by the Faculty of Medicine Siriraj Hospital
Ethical Committee.
The following data were extracted from the medical
records: demographic data (age and gender), clinical
presentations (abdominal pain, abdominal distension,
loss of appetite, nausea, vomiting, diarrhea, weight loss,
splenomegaly, fever, jaundice, ascites, and gastrointest-
inal hemorrhage), complications (esophageal and gastric
varices, variceal hemorrhage, portal hypertensive gastro-
pathy, and ascites), extension of the thrombus (main,
right or left branch of portal vein, mesenteric vein, sple-
nic vein, vena cava), imaging methods used to diagnose
PVT (ultrasound with or without Doppler, computed
tomography (CT), magnetic resonance imaging (MRI) or
magnetic resonance venography (MRV)), and hepatitis
serology (HBV and hepatitis C virus (HCV)). Diagnosis
of portal hypertensive gastropathy and grading of eso-
phageal- and gastric varices was made by means of eso-
phago-gastro-duodenoscopy (EGD). Owing to the
severity of cancer and cirrhosis, the patients were classi-
fied into 2 groups: group 1) patients with cancer or cir-
rhosis and group 2) patients without cancer and
cirrhosis. Patients were also categorized into 4 groups
according to respective ages: group 1) < 20 years, group
2) ≥ 20 to 40 years, group 3) ≥40 to 60 years, and group
4) ≥60 years. Statistical analyses of continuous variables
(mean, standard deviation (SD), and range) and categori-
cal variables (number and percentage) were performed.
A p-value was calculated when indicated.
3. Results
3.1 Incidence of PVT and other abdominal vein
thrombosis
From 2000-2009, 467 hospital charts with designated
ICD-10 codes of 181, I82.2, I82.3, I82.8, I82.9, or K55.0
were identified and extracted from the hospital system.
PVT (I81) was the most commonly identified thrombo-
sis (194 cases, 41.5%) among all abdominal venous
thrombosis as shown in Table 1.
Table 2 delineates the distribution of thrombosis in
the portal system in the 194 patients diagnosed with
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Page 2 of 9PVT. Mainly, the portal vein was solely involved (145
cases, 74.7%). Other branches were less frequently
involved including splenic vein, superior mesenteric
vein, inferior mesenteric vein, and vena cava. The first
diagnosis of PVT was established by ultrasonography
(33 cases, 17%), Doppler ultrasonography (13 cases,
6.7%), CT (139 cases, 71.6%), MRI (2 cases, 1%), and
MRV (7 cases, 3.6%).
3.2 Clinical presentations of patients with PVT
Table 3 shows the demographic data and clinical pre-
sentations of 194 PVT cases. These patients were predo-
minantly males (126 cases, 65%) and aged older than 40
years (74.8%). The mean age at the time of admission
was 50 (range, 0.2-82.9 years) and the affected male
cases were older than the affected female cases (52.4 ±
15.7 SD vs 46.2 ± 20.8 SD, respectively). Only 6.7% of
the cases were aged younger than 20 and 33% were
older than 60. The most common clinical presentation
in the younger patients, age<20 (84.6%) and age 20-39
(61.1%), was splenomegaly whereas in the older patients,
age 40-60 (66.7%) and age>60 (76.6%), was abdominal
distension/ascites. Abdominal distension/ascites was the
most common clinical presentation in both males
(43.8%) and females (25.3%).
There were 144 PVT patients (105 males and 39
females) who were diagnosed with cancer or cirrhosis
with a mean age at the time of diagnosis of 55.8 ± 14.3
(range, 1.9-82.9 years). Fifty PVT patients (21 males and
29 females) with a mean age of 34.2 ± 17.7 (range, 0.2-
65.9 years) did not have detectable cancer and cirrhosis.
There was no age difference between both genders.
Seventy-eight percent of PVT patients with cancer or
cirrhosis presented with abdominal distension/ascites
followed by splenomegaly (50.7%), abdominal pain
(47.2%), jaundice (47.9%), weight loss (39.6%), loss of
appetite (35.4%), nausea (16.7%), hemorrhage (14.6%),
fever (13.9%), vomiting (13.2%), and diarrhea (7.6%), and
1.4% of these patients were asymptomatic. Sixty-six per-
cent of PVT patients without cancer and cirrhosis pre-
sented with splenomegaly followed by abdominal pain
(60%), abdominal distension/ascites (44%), hemorrhage
(28%), nausea (16%), vomiting (12%), weight loss (12%),
fever (12%), loss of appetite (10%), diarrhea (6%), and
jaundice (2%). None of the patients in the latter group
was asymptomatic.
3.3 Risk factors associated with PVT
Risk factors for PVT could be established in the major-
ity of cases (176 cases, 90.7%). Eighty-four cases (43.3%)
had a single risk factor, 89 cases (45.9%) had two risk
factors, and 3 cases (1.5%) had three risk factors. Table
4 summarizes the risk factors identified to be associated
Table 1 Frequency of abdominal vein thrombosis
Thrombosis classified based on ICD-10 codes No. of cases
(%)
Portal vein thrombosis (I81) 194 (41.5)
Mesenteric vein thrombosis (K55.0) 18 (3.9)
Thrombosis of vena cava (I82.2) 81 (17.3)
Thrombosis of renal vein (I82.3) 18 (3.9)
Thrombosis of other specified vein (I82.8) 96 (20.6)
Thrombosis of unspecified vein (I82.9)
Thrombosis of isolated splenic vein
52 (11.1)
3 (0.6)
Thrombosis of vena cava + renal vein 3 (0.6)
Thrombosis of vena cava + other specified veins 1 (0.2)
Thrombosis of vena cava + renal vein + other
specified veins
1 (0.2)
Total cases in this study 467 (100)
Table 2 Distribution of thrombosis in 194 patients with
PVT
Site of thrombotic involvement
# No. of cases (%)
Portal vein only 145 (74.7)
Porto-mesenteric (SMV) 12 (6.2)
Porto-mesenteric (IMV) 0 (0)
Porto-venacaval 2 (1)
Porto-splenic 16 (8.2)
Porto-spleno-mesenteric (SMV) 19 (9.8)
Porto-spleno-mesenteric (IMV) 1 (0.5)
#Imaging modalities for the first diagnosis of PVT included ultrasonography
(17%), Doppler ultrasonography (6.7%), CT (71.6%), MRI (1%), and MRV (3.6%).
Table 3 Clinical presentations of 194 patients with PVT
Sex (M:F) 126:68
Mean age ± SD (range) 50.2 ± 17.9 (0.2-82.9)
- Male (n = 126) 52.4 ± 15.7 (1-80.8)
- Female (n = 68) 46.2 ± 20.8 (0.2-82.9)
Age <20 (no. of cases, %) 13 (6.7)
Age 20-39 (no. of cases, %) 36 (18.6)
Age 40-60 (no. of cases, %) 81 (41.8)
Age >60 (no. of cases, %) 64 (33)
Clinical presentations No. of cases (%)
Asymptomatic 2 (1)
Abdominal distension/ascites 134 (69.1)
Abdominal pain 98 (50.5)
Jaundice 70 (36.1)
Fever 26 (13.4)
Splenomegaly 106 (54.6)
Hemorrhage 35 (18)*
Loss of appetite 56 (28.9)
Weight loss 63 (32.5)
Nausea 32 (16.5)
Vomiting 25 (12.9)
Diarrhea 14 (7.2)
*hematemesis (10), melena (6), hematochezia (3), hematemesis and melena
(11), hematemesis and hematochezia (3), melena and hematochezia (1),
hematemesis, melena and hematochezia (1)
Lertpipopmetha and Auewarakul BMC Gastroenterology 2011, 11:66
http://www.biomedcentral.com/1471-230X/11/66
Page 3 of 9with PVT in this study cohort. The most common cause
was cancer (126 cases, 65%) followed by cirrhosis (98
cases, 50.5%), abdominal intervention (15 cases, 7.7%),
abdominal inflammation/infection (18 cases, 9.3%, and
bone marrow disorders (9 cases, 4.6%). The most com-
mon type of cancer was hepatocellular carcinoma (HCC)
(102/126, 81%) followed by cholangiocarcinoma (CCA)
(16/126, 12.7%), pancreatic carcinoma (3/126, 2.4%), and
liver metastasis (3/126, 2.4%). One case each of gall blad-
der carcinoma, hepatoblastoma, and ovarian carcinoma
was also found. A variety of infections were found to be
associated with PVT including pancreatitis (3), liver
abscess (4), cholangitis (4), splenic abscess (1), cholecysti-
tis (1), omphalitis (1), and abdominal tuberculosis (1).
Risk factors are categorized based on the patients’ age
and gender as shown in Table 5. The most common
risk factor in the patients aged <20 was abdominal
interventions (3 umbilical catheterization and 1 hepa-
tectomy) which was found in 30.8% of the cases.
Almost half of the young cases had unidentifiable risk
factors (46.2%). In contrast, cancer was the predomi-
nant risk factor in the patients aged 20-39 (38.9%),
aged 40-60 (69.1%), and aged >60 (86%). More PVT
male cases had cancer than female PVT cases (74.6% vs
47.1%). Cirrhosis was more frequently found in males
than females (61.9% vs 29.4%). A higher proportion of
females had unidentifiable risks than males (16.2% vs
5.6%, respectively).
Table 4 Risk factors associated with PVT
Malignancy 126 (65)
HCC (102), CCA (16), pancreatic CA (3), gallbladder CA (1), hepatoblastoma (1), ovarian CA (1), secondary malignant neoplasm of liver (2)
Cirrhosis* 98 (50.5)
HBV (38), HCV (12), Alcohol (15), HBV+HCV (2), HBV+alcohol (8), HCV+alcohol (3), cryptogenic (19), autoimmune (1) [Child-Pugh Class: A (29), B (30), C
(30), unknown (9)]
Abdominal intervention 15 (7.7)
Umbilical catheterization (5), splenectomy (2), cholecystectomy (5), hepatectomy (1), percutaneous transhepatic biliary drainage (PTBD) (1), Whipple
operation with revised hepatojejunostomy and T-tube (1)
Abdominal inflammation/infection 18 (9.3)
Pancreatitis (3), liver abscess (4), cholangitis (4), splenic abscess (1), cholecystitis (1), omphalitis (1), abdominal tuberculosis (1), sepsis (3)
Bone marrow (BM) disorders 9 (4.6)
Polycythemia vera (3), primary myelofibrosis (2), essential thrombocytosis (1), paroxysmal nocturnal hemoglobinuria (2), acute myeloid leukemia (1)
Hereditary coagulation defects 1 (0.5)
Protein S deficiency (1)
Anti-phospholipid syndrome 1 (0.5)
Oral contraceptive pills 4 (2)
Others** 2 (1)
Idiopathic causes 18 (9.3)
*Include cases with hepatocellular carcinoma (HCC) (79) and cholangiocarcionoma (CCA) (1)
** Klippel-Trénaunay syndrome (1), splenic lymphangiomatosis (1)
Table 5 Risk factors for PVT according to age and gender
Risk factors* All patients Age range (years) Gender
<20 20-39 40-60 >60 Male Female
N (%)
194 (100)
N (%)
13 (6.7)
N (%)
36 (18.6)
N (%)
81 (41.8)
N (%)
64 (33)
N (%)
126 (65)
N (%)
68 (35.1)
Cirrhosis 98 (50.5) 1 (7.7) 6 (16.7) 52 (64.2) 39 (60.9) 78 (61.9) 20 (29.4)
Malignancy 126 (65) 1 (7.7) 14 (38.9) 56 (69.1) 55 (86) 94 (74.6) 32 (47.1)
Abdominal intervention 15 (7.7) 4 (30.8) 3 (8.3) 6 (7.4) 2 (3.1) 6 (4.8) 9 (13.2)
Abdominal inflammation or infection 18 (9.3) 1 (7.7) 5 (13.9) 7 (8.6) 5 (7.8) 7 (5.6) 8 (11.8)
BM disorders, protein S deficiency, and APS 11 (5.7) 1 (7.7) 3 (8.3) 5 (6.2) 2 (3.1) 5 (4) 6 (8.8)
Oral contraceptive pills 4 (2) 0 (0) 4 (11.1) 0 (0) 0 (0) 0 (0) 4 (5.9)
Others 2 (1) 0 (0) 2 (5.6) 0 (0) 0 (0) 1 (0.8) 1 (1.5)
Idiopathic 18 (9.3) 6 (46.2) 8 (22.2) 3 (3.7) 1 (1.6) 7 (5.6) 11 (16.2)
N, number of cases; BM, bone marrow; APS, anti-phospholipid syndrome
*Some patients had more than one risk factor.
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PVT
The frequency of HBV and HCV infections in patients
with PVT according to the HCC/cirrhosis status, age,
and gender is shown in Table 6. Increasing incidence of
HBV infection was observed with increasing age. None
of the young patients (aged <20) had HBV or HCV
infections whereas about a third of older patients (aged
>40) had HBV infection and less than 3% had HCV
infection. More males with PVT were affected with
HBV than females (39% vs 5.9%, respectively). PVT
patients with HCC or cirrhosis (51/121, 42.1%), espe-
cially in patients aged >40 (44/145, 30.3%) had HBV
infection as the most important risk factor. HCV infec-
tion (17/121, 14%) and HBV/HCV co-infection (2/121,
1.7%) were not as common as compared to HBV infec-
tion alone. Patients without cirrhosis or HCC had a very
low frequency of HBV and HCV infections.
3.5 Distribution of thrombus in PVT patients with or
without cirrhosis and cancer
Table 7 shows the branch distribution of thrombus
according to age and gender. In the young patients
aged < 20 and 20-39 (79.4%), the main branch was
commonly affected whereas in the older patients, the
right branch was slightly more affected than the left
and the main branches. With respect to gender, the
main and the right branches were commonly involved
than the left branch in males (64.8% and 65.6%,
respectively) whereas the main branch was slightly
more affected than other branches in females (62.7%).
The most common distribution of thrombus in the
patients with cancer and cirrhosis was the right
branch whereas in the patients with cirrhosis only was
the main branch. For patients without cancer and cir-
rhosis, the thrombus was equally distributed in all
branches.
More patients in the cirrhosis only group had porto-
mesenteric thrombus (SMV) (5/18) whereas almost half
of the patients with bone marrow (BM) disorders, pro-
tein S deficiency, and anti-phospholipid syndrome (APS)
had portosplenic thrombus (5/11). Two cases of porto-
caval thrombosis were caused by cancer (100%). Porto-
spleno-mesenteric (SMV) thrombus was more com-
monly found in cases without cancer or cirrhosis (10/19,
52.6%).
Table 6 Frequency of HBV and HCV infection in patients with PVT according to HCC/cirrhosis status, age, and gender
Risk factors* PVT with HCC or cirrhosis PVT without HCC and cirrhosis Age (years) Gender
<20 20-39 40-60 >60 Male Female
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
HBV infection
a 51 (42.1) 2 (2.7) 0 (0) 9 (0.25) 27 (33.3) 17 (26.6) 49 (39) 4 (5.9)
HCV infection
b 17 (14) 1 (1.4) 0 (0) 0 (0) 13 (16) 5 (7.8) 12 (9.5) 6 (8.8)
HBV and HCV co-infection
c 2 (1.7) 0 (0) 0 (0) 0 (0) 2 (2.5) 0 (0) 2 (1.6) 0 (0)
*P value between age groups =
a 0.091,
b 0.022,
c 0.420
Table 7 Distribution of thrombus in the portal vein branches based on age and gender
#
Total Right Branch
N (%)
112 (61.9)
Left branch
N (%)
82 (45.3)
Main
N (%)
116 (64.1)
Confluence
N (%)
10 (5.5)
Age (years)
<20 10 4 (40) 2 (20) 7 (70) 0 (0)
20-39 34 17 (50) 12 (35.3) 27 (79.4) 1 (2.9)
40-60 75 47 (62.7) 41 (54.7) 43 (57.3) 5 (6.7)
>60 62 44 (71) 27 (43.5) 39 (62.9) 4 (6.5)
Gender
-Male 122 80 (65.6) 57 (46.7) 79 (64.8) 7 (5.7)
-Female 59 32 (54.2) 25 (42.4) 37 (62.7) 3 (5.2)
PVT with CA or cirrhosis
-CA only
-Cirrhosis only
44
15
32 (72.7)
9 (60)
17 (38.6)
5 (33.3)
26 (59.1)
13 (86.7)
1 (2.3)
0 (0)
-CA with cirrhosis 80 52 (65) 43 (53.8) 43 (53.8) 5 (6.3)
PVT without CA and cirrhosis
-BM disorders and other risks 8 6 (75) 7 (87.5) 6 (75) 1 (12.5)
-Others 34 13 (38.2) 10 (29.4) 28 (82.4) 3 (8.8)
#181 cases had a complete description of involved branches by imaging studies
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A variety of etiologic factors of PVT has previously been
described including hereditary and acquired coagulation
disorders, autoimmune diseases, abdominal infections/
inflammations, abdominal intervention, transplantation,
cirrhosis, and malignancies [11-24]. In this study, the
predominant risk factor was HCC (52.5%), followed by
liver cirrhosis without cancer (9.3%), and abdominal
infections/inflammations (9.3%). Although HCC has
been reported as a risk factor for PVT in the Caucasian
patients [20], the prevalence was not as high as in the
Asian cases. A high prevalence of HCC-associated PVT
was noted in several series requiring therapeutic inter-
ventions in Chinese patients [14,23]. Cirrhosis without
cancer was, in contrast, reported at a higher percentage
as a cause of PVT than our cases. In a study of 172
PVT cases from the Netherlands, 15 cases of HCC and
37 cases of cirrhosis were reported, which represented
8.7% and 21.5% of the total cases, respectively [16]. A
study from Sweden also reported that HCC and cirrho-
sis without cancer could be identified in 23% and 28%
of the 254 PVT cases, respectively, although the exact
etiologies of cirrhosis and HCC were not delineated in
either study [1]. Our results, however, were as expected
with respect to the natural history of cirrhosis and HCC
and its relationship to thrombosis. Increasing incidence
of PVT was observed in patients with liver decompensa-
tion and HCC when compared to patients with well-
compensated cirrhosis [3,17,25].
The most common cause of cirrhosis in this patient
cohort was HBV infection (38/98, 38.8%) which was
much more prevalent than HCV infection (12/98,
12.2%). Alcohol was also the frequent cause of cirrhosis
(15/98, 15.3%), and the combination of HBV, HCV and
alcohol was found in 11 cases (11.2%). Patients without
cirrhosis or HCC had a very low incidence of HBV or
HCV infection. Our study is unique in that the majority
of our PVT cases with underlying cirrhosis and HCC
were associated with chronic HBV infection. HCV infec-
tion was not as prevalent as HBV infection alone as the
cause of PVT which could be explained by the strikingly
low incidence of HCV infection in the Southeast Asian
population as compared to the Western populations
[26,27]. Moreover, alcohol was the most common risk
factor for HCC in a series reported from the United
States [20]. Although HBV vaccination program has
been implemented for all neonates in Thailand since
1992, the majority of our older generation is still not
immunized and at least 4-8% of the population con-
tinues to be affected by the infection [26,28,29]. It is
thus likely that HBV-associated cirrhosis/HCC will con-
tinue to be the major risk factor of PVT in the next few
decades.
The risk factors of PVT appeared to vary according to
age and gender. In young patients aged <20 years, umbi-
lical catheterization was the main risk which was similar
to the study of 31 children with PVT in Italy [30],
whereas in older adults (age 40-60 and >60), malignancy
was the major etiology (69.1% and 86%, respectively).
Only 1 case of cancer, i.e. hepatoblastoma, was found in
a young patient with PVT. Abdominal infection such as
omphalitis which causes thrombophlebitis of the umbili-
cal vein and eventually the portal system was reported
in most pediatric series [21,31] but was found in only 1
case in this study (7.7%). Almost half of our young
patients had unidentifiable risks (46.2%) which could be
attributed to truly idiopathic causes or incomplete
thrombophilic investigations. Although the main limita-
tion of this study is its retrospective nature and a com-
plete set of thrombophilic investigations might not have
been performed in some of these cases in the last 10
years, it should be noted that hereditary thrombophilic
disorders such as Factor V Leiden, prothrombin gene
G20210A mutation, protein C deficiency, protein S defi-
ciency, antithrombin deficiency, and methylenetetrahy-
drofolate reductase (MTFR) gene mutation are very rare
in the Southeast Asian population [32,33]. A study of 61
patients with PVT from India reported only 1 case of
Factor V Leiden and none with prothrombin gene
G20210A mutation [34]. A prospective study should be
performed to further explain these unidentifiable causes.
Regarding the impact of gender, men were more com-
monly affected with cirrhosis and malignancies than
women although both conditions remained the major
risk factors in both genders.
Several risk factors identified in this population have
rarely been described and are remarkably different from
reports from the Western countries. Tuberculosis which
is a prevalent infection in the Southeast Asia region was
also found associated with PVT although abdominal
tuberculosis is not a common manifestation [6]. In this
study, a 32-year-old man who was previously diagnosed
with abdominal tuberculosis came to our hospital
because of hematemesis, melena, and splenomegaly.
Endoscopic studies showed esophago-gastric varices
with portal-hypertensive-gastropathy and CT scan of the
whole abdomen revealed PVT. Two single cases of rare
malformation syndromes such as Klippel-Trénaunay
vascular malformation syndrome [9] and systemic lym-
phangiomatosis [10], which had been sporadically
reported, were also discovered in our series. As for the
first case, a 25-year-old woman came to the hospital
because of epigastric pain radiating to midback asso-
ciated with nausea and vomiting. The patient had sple-
nomegaly and lymphadenopathy and CT study of the
whole abdomen showed portal-spleno-mesenteric vein
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and spleen. A lymph node biopsy revealed lymphan-
gioma; therefore this patient was diagnosed with sys-
temic lymphangiomatosis with PVT which is the first
case ever reported from the Southeast Asian population.
T h es e c o n dc a s ew a sa2 9 - y e a r - o l dm a nw i t hK l i p p e l -
Trénaunay syndrome who came to the hospital because
of epigastric pain radiating to midback and was found
to have an enlarged spleen on examination. He was sub-
sequently found to have portal-spleno-mesenteric vein
thrombosis by CT imaging. This case also represents
the first case of Klippel-Trénaunay syndrome associated
with PVT ever reported from the Southeast Asian
region.
Bone marrow disorders such as paroxysmal nocturnal
hemoglobinuria (PNH) and myeloproliferative neo-
plasms (MPN) including polycythemia vera (PV),
chronic myeloid leukemia (CML), essential thrombocy-
tosis (ET), and primary myelofibrosis (PMF) have been
reported as presenting causes of abdominal venous
t h r o m b o s i s .I nt h i ss t u d y ,w ew e r ea b l et oi d e n t i f yo n l y
2 cases of PNH-associated PVT among 497 medical
charts extracted during a 10-year study period, support-
ing that venous thrombosis is rare in the PNH patients
in Thailand [35] as contrast to the Western series [36].
Moreover, MPN which was found as a potential risk for
PVT in the Western series necessitating a bone marrow
study, endogenous erythroid colony (EEC) culture, and a
JAK2 mutation analysis was infrequently identified in
this cohort [24,37]. Only 3 cases of PV, 2 cases of PMF
and 1 case of ET were discovered.
Other types of malignancies associated with PVT were
also examined. In this study, secondary malignant
tumors of the liver were identified in only 2 cases (1%).
This frequency was much lower than the report by the
Swedish autopsy series which found 111 PVT cases
(44% of 254 cases) with secondary malignancy of the
hepatobiliary region, and the major cause of which was
pancreatic carcinoma (42%) [1]. The differences could
be due to the fact that most autopsy series often
revealed more occult cases of malignancies at the time
of death than the clinical case reports performed while
the patients still alive. Nevertheless, it could be con-
cluded that metastatic cancer to the liver is an uncom-
mon risk factor of PVT in this study. It is of interest to
identify CCA as the second most common type of can-
cer associated with PVT in our population (16 cases,
8.2%). CCA is a rare cancer in the West but its preva-
lence is very high in Thailand and neighboring coun-
tries, the cause of which is mainly associated with
Opisthorchis viverrini infection [38,39].
The clinical presentations of PVT patients in this
study were typical of portal hypertension as a result of
portal vein occlusion. A study from India performed in
children younger than 14 years old showed that in the
developing countries, 73% of extrahepatic portal hyper-
tension were caused by PVT [8]. Splenomegaly which
was the dominant clinical presentation in our patients
without cancer and cirrhosis was consistent with the
Danish’s report [6]. However, most of our patients with
cancer or cirrhosis had a slightly different presentation
from those without cancer or cirrhosis since more cases
in the first group presented with abdominal pain and
ascites while the latter presented with splenomegaly. It
could be argued that the abdominal pain symptom
could be the result of HCC involvement of the liver,
rather than PVT, however, it was too difficult to differ-
entiate one another from the medical records.
It was of interest to find that CT was the most popular
imaging modality for PVT diagnosis in this series. In gen-
eral, Doppler ultrasonography is a preferred screening
tool to diagnose thrombus in the portal system due to its
lower costs, lack of need for intravenous contrast mate-
rial injection, and ease of multiple follow-up examina-
tions [40,41]. However, its sensitivity is operator-
dependent which can vary from 60% to 100% [6,42-44].
CT has become widely available in Thailand for many
years and it could be speculated that CT was performed
in the majority of patients in this series (139 cases,
71.6%) because physicians felt that it was more accurate
and more informative than ultrasonography to confirm
the presence and extent of thrombus as well as to identify
various abdominal etiologies associated with PVT [45].
MRI is another modality that can be used for PVT diag-
nosis with a high accuracy although its true sensitivities
and specificities have never been reported for PVT diag-
nosis [46]. MRI was utilized only in a few patients in this
series (9 cases, 4.6%) due to its limited availability and
associated higher costs than CT and ultrasonography.
With respect to the sites of thrombus formation, it
was of interest to find that the main branch was com-
monly affected in the younger patients whereas the right
branch was slightly more affected than the left branch
in the older patients. The reason why thrombi occur in
different branches of the portal system in young and
older patients remains unclear. However, with respect to
the most common distribution of thrombus in patients
with cancer and cirrhosis, our results were in agreement
with a previous finding from Italy which revealed that
among 701 patients with liver cirrhosis, the thrombus
was found most commonly in the main portal trunk [3].
Moreover, a study from China also showed that the
right branch was the most commonly affected branch in
a series of 108 patients with advanced HCC [47].
5. Conclusion
One hundred and ninety-four cases of PVT were identi-
fied in a 10-year study period. The predominant
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Page 7 of 9identifiable risk factor was chronic HBV infection which
is prevalent in this region and is strongly associated
with cirrhosis and HCC. Interaction of host and envir-
onmental factors may play an important role in the
pathogenesis of PVT in various ethnic populations resid-
ing in heterogeneous geographic regions. Future pro-
spective studies such as gene association studies should
be performed in order to identify the genetic risks and
their modifying factors for PVT in these populations.
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